Nicotinamide Riboside

Nicotinamide riboside functions as a NAD+ precursor that increases intracellular nicotinamide adenine dinucleotide levels, a coenzyme essential for cellular energy metabolism and enzymatic function¹. Clinical evidence supports its use in managing metabolic disorders, neurodegenerative conditions, and age-related pathologies, with oral administration demonstrating consistent elevation of blood NAD+ levels and improved bioavailability compared to other NAD+ precursors¹,². The most reproducible clinical benefit observed across human trials is reduction of inflammatory markers, particularly in aging populations where a standard dose of 1 gram daily for three weeks reduced circulating inflammatory cytokines including IL-2, IL-5, IL-6, and TNFα¹,³. Research indicates therapeutic potential in cardiovascular disease prevention through reduction of blood vessel stiffness and blood pressure, as well as neuroprotective effects in models of neurodegeneration and support for mitochondrial bioenergetics in skeletal muscle¹,²,⁴. Nicotinamide riboside has demonstrated a favorable safety profile with minimal adverse effects or flushing reactions, distinguishing it among NAD+ boosting agents for clinical use⁴.

Nicotinamide riboside (NR), a form of vitamin B3 and NAD+ precursor, is possibly safe when taken orally at doses up to 300 mg daily, with mild side effects commonly reported as nausea, bloating, fatigue, headaches, diarrhea, stomach discomfort, indigestion, itching, sweating, and skin flushing.²,⁵,⁶ No serious adverse effects have been observed in short-term human studies, though larger long-term trials are needed to confirm safety, and animal studies suggest high doses may impair glucose tolerance, induce white adipose tissue dysfunction, or raise tumor risks not yet seen in humans.⁵,⁶,⁷,⁸ During pregnancy or breastfeeding, doses up to 230 mg daily appear possibly safe.⁵ Key safety considerations include starting with low doses, monitoring for persistent symptoms like elevated liver enzymes or blood pressure changes, staying hydrated, and consulting a doctor, especially if allergic reactions (e.g., swelling, breathing issues) or metabolic issues arise, as NR boosts cellular energy metabolism which could amplify sensitivities.⁶,⁷,⁹ High doses of related nicotinamide have shown liver injury or insulin sensitivity reductions in some studies, underscoring caution beyond recommended levels.¹⁰

Nicotinamide riboside (NR) is a precursor to nicotinamide adenine dinucleotide (NAD+), a critical coenzyme involved in cellular energy metabolism, DNA repair, and enzymatic processes such as those catalyzed by sirtuins and ADP-ribosyltransferases.³,¹¹ Upon uptake, NR is phosphorylated by nicotinamide riboside kinases (NRK1 and NRK2) to form nicotinamide mononucleotide (NMN), which is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferase.¹¹,¹² This two- or three-step salvage pathway boosts intracellular NAD+ levels, supporting mitochondrial function and oxidative phosphorylation.⁴,¹³ Downstream effects may include modulation of pathways like JAK2/Stat3 and MAPK, potentially reducing oxidative stress and fibrosis in specific cell types, though these are context-dependent.¹⁴,¹⁵